Category: Consumer goods
Quick infos Trade prices Volume: Market Cap: 63.65M Prev closed: 3.98 Open: 3.97 High: 4.04 Low: 3.82 52 week low: 2.52 52 week high: 9.7 Dividends: No Dividends Next ER: March 30, 2023
Earnings History Date EPS / Forecast Revenue / Forecast May 25, 2023 March 30, 2023 November 9, 2022 -0.18 / -0.325- / 507.5KAugust 5, 2022 0.01 / -0.3- / -May 26, 2022 - / -0.3- / 85.5Kview more
Historical Data Date Price Open High Low Vol Change ER Aug 11, 2022 3.040 3.170 3.170
2.940
202.86K -3.18% Aug 10, 2022 3.140 3.060 3.180
2.959
219.21K 3.29% Aug 9, 2022 3.040 3.060 3.130
2.900
160.57K -2.25% Aug 8, 2022 3.110 3.080 3.150
2.980
387.01K 6.87% Aug 5, 2022 2.910 2.940 2.950
2.750
302.09K -5.21% Aug 4, 2022 3.070 2.820 3.100
2.820
555.16K 10.04% Aug 3, 2022 2.790 2.700 2.840
2.580
301.65K 5.28% Aug 2, 2022 2.650 2.380 2.740
2.300
345.54K 4.74% Aug 1, 2022 2.530 2.900 2.910
2.350
966.54K -7.66% Jul 29, 2022 2.740 2.250 2.900
2.210
1.31M 17.60% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company News
InflaRx GAAP EPS of -$0.18 seekingalpha.com Nov 9, 2022 9:40 pm InflaRx seeks FDA emergency use nod for its treatment for critically ill COVID-19 patients seekingalpha.com Sep 29, 2022 9:34 pm
InflaRx Receives Corrected Advice Letter from FDA Related to Phase III Program for Vilobelimab in Hidradenitis Suppurativa finance.yahoo.com Aug 30, 2022 7:30 am
InflaRx Reports Full Year 2021 Financial and Operating Results finance.yahoo.com Aug 30, 2022 7:30 am
InflaRx Announces Encouraging Phase III Topline Results from PANAMO Trial of Vilobelimab in Severe COVID-19 Patients finance.yahoo.com Aug 30, 2022 7:30 am InflaRx reports Q2 results seekingalpha.com Aug 5, 2022 7:28 pm
InflaRx Announces Plans to Apply for Emergency Use Authorization from the US FDA for Vilobelimab for Treatment of Critically Ill COVID-19 Patients finance.yahoo.com Aug 30, 2022 7:30 am
30 Stocks Moving in Thursday's Pre-Market Session finance.yahoo.com Aug 30, 2022 7:10 am
Here's Why InflaRx N.V. (IFRX) is a Great Momentum Stock to Buy finance.yahoo.com Aug 17, 2022 12:00 pm
InflaRx Reports Second Quarter 2022 Financial & Operating Results finance.yahoo.com Aug 5, 2022 7:00 am InflaRx stock rises 13% on plans to file EUA for COVID drug in US for critically ill patients seekingalpha.com Jul 26, 2022 9:44 pm InflaRx stock rises 14% as vilobelimab gets FDA fast track status for skin disorder seekingalpha.com Jul 6, 2022 7:47 pm InflaRx granted FDA Type B meeting to discuss submissions for COVID therapy seekingalpha.com Jun 29, 2022 8:17 pm
InflaRx Provides Development Update For Vilobelimab In Skin Disorder, COVID-19 finance.yahoo.com Jun 29, 2022 12:02 pm InflaRx stock soars 18% on vilobelimab getting FDA orphan drug status for skin disorder seekingalpha.com Jun 28, 2022 6:22 pm
InflaRx to Present at the H.C. Wainwright Global Investment Conference finance.yahoo.com May 17, 2022 7:30 am InflaRx GAAP EPS of -€0.32 seekingalpha.com May 12, 2022 8:21 pm
InflaRx Reports First Quarter 2022 Financial and Operating Results and Provides Strategic Update finance.yahoo.com May 12, 2022 7:30 am InflaRx vilobelimab fails to show statistical significance in severe COVID patients in trial seekingalpha.com Mar 31, 2022 8:19 pm InflaRx GAAP EPS of -€1.10 seekingalpha.com Mar 24, 2022 7:38 pm This company doesn't provide a dividend.
Key Persons Talk about InflaRx NV below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
Consensus BUY 75 HOLD 25 SELL 0
If you want to help pay for server cost or for improving this tool. You can send it via Paypal . More features coming soon :)
Buy on Amazon In the world of investing, slow and steady wins the race. With this mantra in mind, trusted author and finance guru Eric Tyson is back with the latest edition of the #1 bestselling book, Investing For Dummies, to help you achieve your investment goals.